Lobular carcinoma in situ (LCIS) is a rare condition in which abnormal cells form in the breast's milk glands (lobules). LCIS is not breast cancer, but it indicates an increased risk of developing breast cancer. People with lobular carcinoma in situ are ten times more likely to develop breast cancer than those who do not have this condition. LCIS is asymptomatic. The doctor may discover LCIS incidentally while performing a biopsy to evaluate a lump in your breast. Treatment for LCIS may include biopsy, careful observation, chemoprevention, and risk reduction surgery.
All the answers published in this website are written by verified medical doctors, therapists and health experts. The Content has been moderated by iCliniq medical review team before publication. Post your medical clarifications on iCliniq by choosing the right specialty and get them answered. Your medical queries will be answered 24/7 by top doctors from iCliniq.
Why does my pathology report not include classification of my LCIS?
Query: Hello doctor, Why does my pathology report not include classification of my LCIS? Read Full »
Answer: Hello, Welcome to icliniq.com. LCIS (lobular carcinoma in situ) is not cancer in comparison to that of ductal carcinoma in situ. In LCIS, abnormal cells grow in lobules. It can be converted into invasive cancer in the future in some cases. LCIS itself is one of the classifications of a breast tumo... Read Full »
Ask a Specialist Now
Get Expert advice/consultation in 3 stepsChat with a Doctor
Starting @ just $59